Peptide Knowledge Base · GH-axis
GHRP-2: what it is, what the evidence says, and its real status
A second-generation GH-releasing peptide, more selective than GHRP-6 but still restricted and research-only.
Short version: GHRP-6's tidier sibling, a bit more selective, still restricted and WADA-banned. Education only; the legal GH-axis answer is Sermorelin.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: Restricted · research-only · Education only.
Not available. GHRP-2 is a research-only GH-releasing peptide in the restricted group on the FDA Tracker, prohibited in sport (WADA S2). Not FDA-approved, education only.
How does GHRP-2 work?
A ghrelin-receptor agonist that releases growth hormone with somewhat less appetite stimulation than GHRP-6.
What it does — and what it does not do
What it does: Raises growth hormone; used historically in performance contexts.
What it does not do: It is not approved or available, and remains a restricted research compound.
How honest is the evidence?
Evidence grade D — older data; restricted; prolactin/cortisol effects milder than GHRP-6. Read our grading methodology for what each grade means.
What we still don't know: Long-term endocrine effects are poorly characterized.
WADA status: Banned (S2).
How it is taken
Not offered; education only.
Who should not take it
WADA S2 banned; prolactin/cortisol effects; not characterized for safe human use.
Sources
GHRP-2 GH-secretagogue literature; FDA compounding restriction list
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.